Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

    Life Insurance March 25, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    The European Insurance and Occupational Pensions Authority (EIOPA) has turned its head towards the almost zeitgeist topic of ‘private equity’ ownership of life insurers. On 3rd February, it published ‘Consultation on supervisory statement on the authorisation and ongoing supervision of (re-)insurance undertakings related to private equity’, a new consultation paper that is “seeking to address the risks and ensure high-quality and convergent supervision of (re-)insurance undertakings related to private equity firms, considering their specific nature and risks.” 

    While not being a Supervisory Statement as yet, this Consultation Paper could be seen as a new ‘manual of expectations’ for national regulators. The document covers four main areas: the PE firm’s acquisition strategy and business model; governance and conflicts of interest; prudential aspects; and leverage. 

    According to Luca Tres, Head of Strategic Risk and Capital Life Solutions, EMEA at Guy Carpenter, the paper connects to prior efforts.  

    “There is ‘fil rouge’ here. This is an EIOPA supervisory trajectory that started with their work on run-off in 2022 and 2023. There the authority had already pointed to the growing financial investors’ role in the industry and the potential implications. The current document continues that work,” he said. 

    “Anything EIOPA touches on this document is not new. It is already the common supervisory practice in a number of jurisdictions. The real focus here seems to be convergence across supervisory practices.” 

    The use of private credit and other alternative assets by PE-backed insurers gets a mention in the consultation. This has been a bone of contention in the US in the past few years with regards to the pension risk transfer market as class action lawsuits claiming that some plan sponsors do not select the ‘safest annuity available’ (as mandated by ERISA) for their de-risking partner. 

    The UK regulator the Prudential Regulation Authority has also weighed in on the topic, making a few comments relating to its concerns about the prevalence of the use of funded reinsurance to reinsure bulk purchase annuity liabilities. 

    Therefore, it is perhaps of little surprise that EIOPA also has a view but according to Tres, the debate isn’t about the assets themselves. 

     “Private assets are not inherently good or bad, but they can be riskier when governance and investment capabilities are not sophisticated enough,” he said. 

    The requirement for adequate expertise in asset management is not necessarily a new one per se – Article 132 of the existing Solvency II regulations is the ‘prudent person principle’. And indeed, other notable takeaways from EIOPA’s consultation appear to be reminders and/or variations on an existing requirement. 

    Among these is EIOPA’s suggestion that an acquiring PE firm submit a three-year business plan to the national regulators so that they can “assess how the future business model of the undertaking will allow it to comply with the prudential requirements laid down in Article 59(1)(d) of the Solvency II Directive, especially if undertakings’ revenues and/or solvency position is expected to be optimized.” 

    EIOPA’s paper also says that if the information provided is not considered sufficient, national regulators might want to think about requiring the minutes of the PE investment committee or the Board that has decided on the acquisition. 

    This might sound intrusive on the surface, but again, Solvency II’s Own Risk and Solvency Assessment (ORSA) already requires forward-looking, multi-year business/solvency projections. 

    “EIOPA is not building a PE-specific regulatory regime here. What it is doing is aligning insurance supervision with how sophisticated M&A and financial supervision is already conducted in some jurisdictions and, as discussed, standardising it across member states,” said Tres.  

    “It is worth reminding that the regulatory convergence topic across member states and their supervisory authorities is surely a key priority for EIOPA. This document is part of that trajectory,” he added. 

    The consultation paper covers other topics, of course. Governance and conflicts of interest being another significant one (where EIOPA wants to ensure that asset management decisions remain independent, for example) and comments on leverage, capital enhancements and financing (EIOPA requires stress testing of debt repayment, scrutiny of liens/pledges, tailored reporting, and ORSA scenarios to protect solvency and liquidity). 

    Responses to EIOPA’s consultation are due at the end of April and it would not be a surprise if responses are plentiful. But for Tres, if you dispassionately look at the paper, it’s not anti-private equity. 

    “This is not a compatibility issue. EIOPA isn’t saying that private equity funds and other asset managers can’t be players in this market. EIOPA’s guidance reads more like a supervisory reminder: where ownership structures are complex or incentives could favour value extraction over resilience, supervisors should increase scrutiny. It’s essentially a nudge — perhaps amplified because the issue is topical,” he said. 

    EIOPA had not replied to the offer to provide a comment prior to publication. 

    2026 - March Alternative Credit Volume 2 Issue 4 – April 2026
    Share. Twitter LinkedIn Email

    Related Posts

    Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

    April 22, 2026By Greg Winterton

    Editor’s Letter – Volume 2, Issue 4, April 2026

    April 9, 2026By Chris Wells

    Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions

    April 9, 2026By Greg Winterton

    Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

    April 9, 2026By Mark McCord
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.